803 related articles for article (PubMed ID: 18055857)
1. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
2. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
3. Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.
Saraiya B; Goodin S
Pharmacotherapy; 2009 Nov; 29(11):1344-56. PubMed ID: 19857150
[TBL] [Abstract][Full Text] [Related]
4. Prevention of deep vein thrombosis in cancer patients.
Lee AY
Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
Petersen LJ
Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated venous thrombosis in the surgical setting.
Behranwala KA; Williamson RC
Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
8. VTE in patients with cancer--diagnosis, prevention, and treatment.
Lee A
Thromb Res; 2008; 123 Suppl 1():S50-4. PubMed ID: 18824256
[TBL] [Abstract][Full Text] [Related]
9. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
Cohen AT; Nandini B; Wills JO; Ota S
Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in the medically ill patient: a call to action.
Bergmann JF; Kher A
Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
[TBL] [Abstract][Full Text] [Related]
11. Treatment of venous thromboembolism in cancer patients.
Petralia GA; Kakkar AK
Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
[TBL] [Abstract][Full Text] [Related]
12. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
13. [Venous thromboembolism prophylaxis in internal medicine].
Malý J; Widimský J; Dulícek P
Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
[TBL] [Abstract][Full Text] [Related]
14. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
[TBL] [Abstract][Full Text] [Related]
15. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
Lee AY
Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
[TBL] [Abstract][Full Text] [Related]
16. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
[TBL] [Abstract][Full Text] [Related]
18. Management of venous Thromboembolism in cancer: a brief review of risk-benefit approaches and guidelines' recommendations.
Djulbegovic B
J Support Oncol; 2010; 8(2):84-91. PubMed ID: 20464888
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
20. Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?
Turpie AG
J Thromb Haemost; 2007 Jan; 5(1):5-11. PubMed ID: 17059417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
